Posted by Michael Wonder on 25 Oct 2023
Baricitinib for the treatment of patients with severe alopecia areata (update)
25 October 2023 - NICE has published final evidence-based recommendations on the use of baricitinib (Olumiant) for the treatment of patients with severe alopecia areata.
Baricitinib is not recommended for the treatment of adults with severe alopecia areata.
